Cargando…

Efficacy and Safety of Echinacoside in a Rat Osteopenia Model

This study aimed to investigate the efficacy and safety of echinacoside (ECH) using an osteopenia rat model. Forty-eight 6-month-old female Sprague-Dawley rats were randomly divided into one sham-operated group (SHAM) and five OVX (ovariectomized) subgroups: SHAM with vehicle 0.5% carboxymethylcellu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiaolin, Li, Fei, Yang, Yanan, Shen, Jinyang, Zou, Run, Zhu, Panpan, Zhang, Chunfeng, Yang, Zhonglin, Li, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615573/
https://www.ncbi.nlm.nih.gov/pubmed/23573159
http://dx.doi.org/10.1155/2013/926928
_version_ 1782265017992740864
author Yang, Xiaolin
Li, Fei
Yang, Yanan
Shen, Jinyang
Zou, Run
Zhu, Panpan
Zhang, Chunfeng
Yang, Zhonglin
Li, Ping
author_facet Yang, Xiaolin
Li, Fei
Yang, Yanan
Shen, Jinyang
Zou, Run
Zhu, Panpan
Zhang, Chunfeng
Yang, Zhonglin
Li, Ping
author_sort Yang, Xiaolin
collection PubMed
description This study aimed to investigate the efficacy and safety of echinacoside (ECH) using an osteopenia rat model. Forty-eight 6-month-old female Sprague-Dawley rats were randomly divided into one sham-operated group (SHAM) and five OVX (ovariectomized) subgroups: SHAM with vehicle 0.5% carboxymethylcellulose sodium (0.5% CMC-Na) and OVX with vehicle (OVX), OVX with 17β-estradiol (E2), and OVX with ECH of graded doses (ECH-L, ECH-M, and ECH-H). The effects of ECH and E2 on serum biochemical parameters, bone mineral density (BMD), bone biomechanical properties, bone microarchitecture, and immunohistochemistry were examined, and safety assessments were also evaluated. The results showed that ECH treatments improved total femur BMD, bone microarchitecture, and biomechanical properties and decreased serum marker levels in comparison to OVX group. Moreover, ECH administration significantly increased osteoprotegerin (OPG) level, and decreased receptor activator of nuclear factor-κB ligand (RANKL) level in serum, as well as in proximal femur. Importantly, ECH treatment ameliorated the lipid parameters without the overall incidences of adverse events of uterus and mammary gland compared to OVX and SHAM groups. This study demonstrated that administration of ECH for 12 weeks can effectively and safely prevent OVX-induced osteoporosis in rats via increasing the OPG/RANKL ratio.
format Online
Article
Text
id pubmed-3615573
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36155732013-04-09 Efficacy and Safety of Echinacoside in a Rat Osteopenia Model Yang, Xiaolin Li, Fei Yang, Yanan Shen, Jinyang Zou, Run Zhu, Panpan Zhang, Chunfeng Yang, Zhonglin Li, Ping Evid Based Complement Alternat Med Research Article This study aimed to investigate the efficacy and safety of echinacoside (ECH) using an osteopenia rat model. Forty-eight 6-month-old female Sprague-Dawley rats were randomly divided into one sham-operated group (SHAM) and five OVX (ovariectomized) subgroups: SHAM with vehicle 0.5% carboxymethylcellulose sodium (0.5% CMC-Na) and OVX with vehicle (OVX), OVX with 17β-estradiol (E2), and OVX with ECH of graded doses (ECH-L, ECH-M, and ECH-H). The effects of ECH and E2 on serum biochemical parameters, bone mineral density (BMD), bone biomechanical properties, bone microarchitecture, and immunohistochemistry were examined, and safety assessments were also evaluated. The results showed that ECH treatments improved total femur BMD, bone microarchitecture, and biomechanical properties and decreased serum marker levels in comparison to OVX group. Moreover, ECH administration significantly increased osteoprotegerin (OPG) level, and decreased receptor activator of nuclear factor-κB ligand (RANKL) level in serum, as well as in proximal femur. Importantly, ECH treatment ameliorated the lipid parameters without the overall incidences of adverse events of uterus and mammary gland compared to OVX and SHAM groups. This study demonstrated that administration of ECH for 12 weeks can effectively and safely prevent OVX-induced osteoporosis in rats via increasing the OPG/RANKL ratio. Hindawi Publishing Corporation 2013 2013-03-20 /pmc/articles/PMC3615573/ /pubmed/23573159 http://dx.doi.org/10.1155/2013/926928 Text en Copyright © 2013 Xiaolin Yang et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yang, Xiaolin
Li, Fei
Yang, Yanan
Shen, Jinyang
Zou, Run
Zhu, Panpan
Zhang, Chunfeng
Yang, Zhonglin
Li, Ping
Efficacy and Safety of Echinacoside in a Rat Osteopenia Model
title Efficacy and Safety of Echinacoside in a Rat Osteopenia Model
title_full Efficacy and Safety of Echinacoside in a Rat Osteopenia Model
title_fullStr Efficacy and Safety of Echinacoside in a Rat Osteopenia Model
title_full_unstemmed Efficacy and Safety of Echinacoside in a Rat Osteopenia Model
title_short Efficacy and Safety of Echinacoside in a Rat Osteopenia Model
title_sort efficacy and safety of echinacoside in a rat osteopenia model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615573/
https://www.ncbi.nlm.nih.gov/pubmed/23573159
http://dx.doi.org/10.1155/2013/926928
work_keys_str_mv AT yangxiaolin efficacyandsafetyofechinacosideinaratosteopeniamodel
AT lifei efficacyandsafetyofechinacosideinaratosteopeniamodel
AT yangyanan efficacyandsafetyofechinacosideinaratosteopeniamodel
AT shenjinyang efficacyandsafetyofechinacosideinaratosteopeniamodel
AT zourun efficacyandsafetyofechinacosideinaratosteopeniamodel
AT zhupanpan efficacyandsafetyofechinacosideinaratosteopeniamodel
AT zhangchunfeng efficacyandsafetyofechinacosideinaratosteopeniamodel
AT yangzhonglin efficacyandsafetyofechinacosideinaratosteopeniamodel
AT liping efficacyandsafetyofechinacosideinaratosteopeniamodel